Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Therapeutic collaboration (compliance): Content of the definition, mechanisms of formation, and methods of optimization

https://doi.org/10.14412/2074-2711-2014-2-4-12

Full Text:

Abstract

Тhe article discusses the role of therapeutic collaboration (compliance) in the efficiency of a treatment process. It analyzes the relationship between the quality of compliance and psychological, clinical, therapeutic, social factors and specific features of medical care. There are data on the efficiency of current methods for optimizing therapeutic compliance. The quality of compliance in different diseases is discussed.

Recommendations are given to improve its quality in cardiovascular, chronic infectious diseases, cancers, skin, neurological, and mental diseases in children and elderly patients.

About the Author

D.S. Danilov
University Clinical Hospital Three I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow
Russian Federation

S.S. Korsakov Clinic of Psychiatry

«Mental Health» Research, Education and Clinical Center



References

1. Sackett DL. Introduction and the magnitude of compliance and noncompliance. In: Compliance with therapeutic regimens. Sackett DL, Haynes RB, editors. Baltimore: Johns Hopkins University Press; 1976. P. 1–25.

2. Haynes RB. Introduction. In: Compliance in Health Care. Haynes RB, Sackett DL, Taylor DW, editors. Baltimore: Johns Hopkins University Press; 1979. P. 1–18.

3. Ястребов ВС. Проблемы патернализма и партнерства в психиатрии. Психиатрия. 2012:4(56);7–13. [Yastrebov VS. Paternalism and partnership problems in psychiatry. Psikhiatriya. 2012:4(56);7–13. (In Russ.)]

4. Данилов ДС. Индивидуальный выбор современной психофармакотерапии шизофрении (основные принципы, обсуждение результатов клинических исследований и некоторые практические рекомендации). Психиатрия и психофармакотерапия. 2008;10(6):50–7. [Danilov DS. Individual choice of modern psychopharmacotherapy of schizophrenia (basic principles, discussion of results of clinical trials and some practical recommendations). Psikhiatriya i psikhofarmakoterapiya.

5. ;10(6):50–7. (In Russ.)]

6. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003, 212 p.

7. Hogan TP, Award AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine. 1983;13(1):177–83. DOI:http://dx.doi.org/10.1017/S0033291700050182.

8. Weiden P, Rapkin B, Mott T, et al. Rating of medication influences (ROMI) scale in schizophrenics. Schizophrenia Bull. 1994;20(2):297–310. DOI:http://dx.doi.org/10.1093/schbul/20.2.297.

9. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for psychosis. Schizoph Res. 2000;42(3):241–7. DOI:http://dx.doi.org/10.1016/S0920-9964(99)00130-9.

10. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a selfreported measure of medication adherence. Med Care. 1986;24(1):67–74. DOI:http://dx.doi.org/10.1097/00005650-198601000-00007.

11. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: the development and evaluation of treatment: reliability a new method for assessing the cognitive representation of medication. Psychological Health. 1999;14:1–24. DOI:http://dx.doi.org/10.1080/08870449908407311.

12. Kampman O, Lehtinen K, Lassila V, et al. Attitudes towards neuroleptic and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire. Schizoph Res. 2000;45(3):223–34. DOI:http://dx.doi.org/10.1016/S0920-9964(99)00204-2.

13. Лутова НБ, Борцов АВ, Вукс АЯ и др. Метод прогнозирования медикаментозного комплаенса в психиатрии (методические рекомендации). Санкт-Петербург: ИЦ С-Пб НИПНИ им. В.М. Бехтерева; 2007. 25 с. [Lutova NB, Bortsov AV, Vuks AYa, et al. Metod prognozirovaniya medikamentoznogo komplaensa v psikhiatrii (metodicheskie rekomendatsii) [Method of forecasting medicamentous komplaens in psychiatry (methodical recommendations)]. St-Petersburg: ITs S-Pb NIPNI im. V.M. Bekhtereva; 2007. 25 p.]

14. Carter S, Taylor D, Levenson R. A question of choice – compliance in medicine taking: A preliminary review. 3rd ed. London: Medicines Partnership; 2005. 101 p.

15. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. ArchIntern Med. 1990;150(7):1509–10. DOI:http://dx.doi.org/10.1001/archinte.1990.00390190143023.

16. Наумова ЕА, Шварц ЮГ. Выполнение больными врачебных назначений: эффективны ли вмешательства, направленные на улучшение этого показателя? Международный журнал медицинской практики. 2006;(1):48–60. [Naumova EA, Shvarts YuG. Performance by patients of medical appointments: whether the interventions directed on improvement of this indicator are effective? Mezhdunarodnyi zhurnal meditsinskoi praktiki. 2006;(1):48–60. (In Russ.)]

17. Tucker CM, Petersen S, Herman KC, et al. Self-regulation predictors of medication adherence among ethnically different pediatric patients with renal transplants. J Pediatr Psychol. 2001:26(8):455–64. DOI:http://dx.doi.org/10.1093/jpepsy/26.8.455.

18. Byrd ChE. Understanding adherence to the typical anti-hypertensive treatment regimen: An expanded self-regulation theory based prediction model. A dissertation for the degree of doctor of philosophy. Gainesville. 2004. 190 p.

19. Kemp R, David A, Hayward P. Compliance therapy: an intervention targeting insight and treatment adherence in psychotic patients. Behavioral and Cognitive Psychotherapy. 1996;24(4):331–50. DOI:http://dx.doi.org/10.1017/S135246580001523X.

20. Шлафер АМ. Метод комплаенс-терапии в системе лечения больных шизофренией. Автореф. дисс. … канд. мед. наук. Санкт-Петербург. 2012. 26 с. [Shlafer AM. Metod komplaens-terapii v sisteme lecheniya bol'nykh shizofreniei [Komplayens-therapy method in system of treatment of patients with schizophrenia]. Avtoref. diss . … kand. med. nauk. St-Petersburg. 2012. 26 р.]

21. Коркина МВ, Цивилько МА, Кисляк ОА и др. Выраженность алекситимии и уровень комплайенса у больных, перенесших инфаркт миокарда. Социальная и клиническая психиатрия. 1999;9(4):20–2. [Korkina MV, Tsivil'ko MA, Kislyak OA, et al. Expressiveness of an aleksitimiya and level compliance at the patients who have had a myocardial infarction. Sotsial'naya i klinicheskaya psikhiatriya. 1999;9(4):20–2. (In Russ.)]

22. Goudge J, Ngoma B, Schneider H. Adherence to anti-retroviral drugs: Theorising contextual relationships. Johannesburg: Centre for Health Policy; 2004. 35 p.

23. Vik SA, Maxwell CJ, Hogan DB, et al. Assessing medication adherence among older persons in community settings. Canadian J Clin Pharmacol. 2005;12(1):152–64.


For citation:


Danilov D. Therapeutic collaboration (compliance): Content of the definition, mechanisms of formation, and methods of optimization. Neurology, Neuropsychiatry, Psychosomatics. 2014;6(2):4-12. (In Russ.) https://doi.org/10.14412/2074-2711-2014-2-4-12

Views: 702


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)